Related references
Note: Only part of the references are listed.GSK3β mediates the spatiotemporal dynamics of NLRP3 inflammasome activation
Suyavaran Arumugam et al.
CELL DEATH AND DIFFERENTIATION (2022)
Discovery of Azaindolin-2-One as a Dual Inhibitor of GSK3β and Tau Aggregation with Potential Neuroprotective Activity
Taha F. S. Ali et al.
PHARMACEUTICALS (2022)
PKR kinase directly regulates tau expression and Alzheimer's disease-related tau phosphorylation
Lasse Reimer et al.
BRAIN PATHOLOGY (2021)
An Integrated Bioinformatics Study of a Novel Niclosamide Derivative, NSC765689, a Potential GSK3 beta/beta-Catenin/STAT3/CD44 Suppressor with Anti-Glioblastoma Properties
Ntlotlang Mokgautsi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Structure-Based Design of Potent Selective Nanomolar Type-II Inhibitors of Glycogen Synthase Kinase-3β
Matthew P. Davies et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Revisiting the Role of GSK3, A Modulator of Innate Immunity, in Idiopathic Inclusion Body Myositis
Manuela Piazzi et al.
CELLS (2021)
Design and Microwave Synthesis of New (5Z) 5-Arylidene-2-thioxo-1,3-thiazolinidin-4-one and (5Z) 2-Amino-5-arylidene-1,3-thiazol-4(5H)-one as New Inhibitors of Protein Kinase DYRK1A
Khadidja Bourahla et al.
PHARMACEUTICALS (2021)
A novel GSK-3 inhibitor binds to GSK-3β via a reversible, time and Cys-199-dependent mechanism
Davoud Ghazanfari et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2021)
Discovery of Novel Benzothiazepinones as Irreversible Covalent Glycogen Synthase Kinase 3β Inhibitors for the Treatment of Acute Promyelocytic Leukemia
Peng Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Functionalization of 9-thioxanthone at the 1-position: From arylamino derivatives to [1] benzo(thio)pyrano [4,3,2-de]benzothieno[2,3-b]quinolines of biological interest
Nahida Mokhtari Brikci-Nigassa et al.
BIOORGANIC CHEMISTRY (2020)
Glycogen Synthase Kinase 3 (GSK3): Its Role and Inhibitors
Pankaj Wadhwa et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2020)
Modulation of LPS-induced inflammatory cytokine production by a novel glycogen synthase kinase-3 inhibitor
Mahboubeh S. Noori et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
GSK3α: An Important Paralog in Neurodegenerative Disorders and Cancer
Octavio Silva-Garcia et al.
BIOMOLECULES (2020)
Structural modeling of GSK3β implicates the inactive (DFG-out) conformation as the target bound by TDZD analogs
Meenakshisundaram Balasubramaniam et al.
SCIENTIFIC REPORTS (2020)
From simple quinoxalines to potent oxazolo[5,4-f]quinoxaline inhibitors of glycogen-synthase kinase 3 (GSK3)
Frederic Lassagne et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2020)
Synthesis and biological evaluation of 3-substituted 2-oxindole derivatives as new glycogen synthase kinase 3β inhibitors
Natalia A. Lozinskaya et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2019)
Inclusion body myositis: clinical features and pathogenesis
Steven A. Greenberg
NATURE REVIEWS RHEUMATOLOGY (2019)
Design, Synthesis and in Vitro Tumor Cytotoxicity Evaluation of 3,5-Diamino-N-substituted Benzamide Derivatives as Novel GSK-3β Small Molecule Inhibitors
Yanping Zhou et al.
CHEMISTRY & BIODIVERSITY (2019)
Discovery of novel glycogen synthase kinase-3α inhibitors: Structure-based virtual screening, preliminary SAR and biological evaluation for treatment of acute myeloid leukemia
Yanxing Wang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Identification of a novel selective and potent inhibitor of glycogen synthase kinase-3
Mahboubeh S. Noori et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2019)
Pyridinylimidazoles as dual glycogen synthase kinase 3β/p38α mitogen-activated protein kinase inhibitors
Fabian Heider et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Niclosamide repositioning for treating cancer: Challenges and nano-based drug delivery opportunities
Eduardo Jose Barbosa et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2019)
Identification of dual kinase inhibitors of CK2 and GSK3β: combined qualitative and quantitative pharmacophore modeling approach
Triveni Pardhi et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2018)
Glycogen synthase kinase-3 and its inhibitors: Potential target for various therapeutic conditions
A. Prasanth Saraswati et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
In Vitro and In Vivo Antitumor and Anti-Inflammatory Capabilities of the Novel GSK3 and CDK9 Inhibitor ABC1183
Randy S. Schrecengost et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2018)
A Diverse and Versatile Regiospecific Synthesis of Tetrasubstituted Alkylsulfanylimidazoles as p38 Mitogen-Activated Protein Kinase Inhibitors
Francesco Ansideri et al.
MOLECULES (2018)
Design, synthesis, and evaluation of 4,5,6,7-tetrahydrobenzo[d]thiazole-based novel dual kinase inhibitors of CK2 and GSK3β
Triveni R. Pardhi et al.
MEDCHEMCOMM (2018)
Paneth Cells Respond to Inflammation and Contribute to Tissue Regeneration by Acquiring Stem-like Features through SCF/c-Kit Signaling
Mark Schmitt et al.
CELL REPORTS (2018)
Kororamides, Convolutamines, and Indole Derivatives as Possible Tau and Dual-Specificity Kinase Inhibitors for Alzheimer's Disease: A Computational Study
Laura Llorach-Pares et al.
MARINE DRUGS (2018)
Kinome chemoproteomics characterization of pyrrolo[3,4-c]pyrazoles as potent and selective inhibitors of glycogen synthase kinase 3
Martin Golkowski et al.
MOLECULAR OMICS (2018)
Identification of two potential glycogen synthase kinase 3 beta inhibitors for the treatment of osteosarcoma
Kaimin Lu et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2018)
Tri- and Tetrasubstituted Pyridinylimidazoles as Covalent Inhibitors of c-Jun N-Terminal Kinase 3
Felix Muth et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Optimized 4,5-Diarylimidazoles as Potent/Selective Inhibitors of Protein Kinase CK1δ and Their Structural Relation to p38α MAPK
Jakob Halekotte et al.
MOLECULES (2017)
Stressed and Inflamed, Can GSK3 Be Blamed?
Richard S. Jope et al.
TRENDS IN BIOCHEMICAL SCIENCES (2017)
GSK3 Inhibitors in the Therapeutic Development of Diabetes, Cancer and Neurodegeneration: Past, Present and Future
Mudasir Maqbool et al.
CURRENT PHARMACEUTICAL DESIGN (2017)
Effects of mutations in Wnt/β-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activity-Diverse effects on cell growth, metabolism and cancer
James A. McCubrey et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2016)
Tau mis-splicing in the pathogenesis of neurodegenerative disorders
Sun Ah Park et al.
BMB REPORTS (2016)
Diaminothiazoles evade multidrug resistance in cancer cells and xenograft tumour models and develop transient specific resistance: understanding the basis of broad-spectrum versus specific resistance
Smreti Vasudevan et al.
CARCINOGENESIS (2015)
Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases
Eleonore Beurel et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Tetra-Substituted Pyridinylimidazoles As Dual Inhibitors of p38α Mitogen-Activated Protein Kinase and c-Jun N-Terminal Kinase 3 for Potential Treatment of Neurodegenerative Diseases
Felix Muth et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Conformational Analysis of the DFG-Out Kinase Motif and Biochemical Profiling of Structurally Validated Type II Inhibitors
R. S. K. Vijayan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
PhosphoSitePlus, 2014: mutations, PTMs and recalibrations
Peter V. Hornbeck et al.
NUCLEIC ACIDS RESEARCH (2015)
Reversible Action of Diaminothiazoles in Cancer Cells Is Implicated by the Induction of a Fast Conformational Change of Tubulin and Suppression of Microtubule Dynamics
Nisha E. Thomas et al.
MOLECULAR CANCER THERAPEUTICS (2014)
A randomized, phase 2 clinical trial of lithium carbonate in Machado-Joseph disease
Jonas Alex Morales Saute et al.
MOVEMENT DISORDERS (2014)
Treatment of Alzheimer's Disease with the GSK-3 Inhibitor Tideglusib: A Pilot Study
Teodoro del Ser et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Sustained Interleukin-1β Overexpression Exacerbates Tau Pathology Despite Reduced Amyloid Burden in an Alzheimer's Mouse Model
Simantini Ghosh et al.
JOURNAL OF NEUROSCIENCE (2013)
Cytokines in Sepsis: Potent Immunoregulators and Potential Therapeutic Targets-An Updated View
Wibke Schulte et al.
MEDIATORS OF INFLAMMATION (2013)
Azaindole-Based Inhibitors of Cdc7 Kinase: Impact of the Pre-DFG Residue, Val 195
Yunsong Tong et al.
ACS MEDICINAL CHEMISTRY LETTERS (2013)
Glycogen Synthase Kinase 3-β: A Master Regulator of Toll-like Receptor-mediated Chronic Intestinal Inflammation
Claudia Hofmann et al.
INFLAMMATORY BOWEL DISEASES (2010)
Alzheimer's disease: strategies for disease modification
Martin Citron
NATURE REVIEWS DRUG DISCOVERY (2010)
Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3)
Eleonore Beurel et al.
TRENDS IN IMMUNOLOGY (2010)
Staphylococcus aureus Induces Microglial Inflammation via a Glycogen Synthase Kinase 3β-Regulated Pathway
Yi-Lin Cheng et al.
INFECTION AND IMMUNITY (2009)
GSK-3: A Key Player in Neurodegeneration and Memory
Karl Peter Giese
IUBMB LIFE (2009)
Inflammation induces tau pathology in inclusion body myositis model via glycogen synthase kinase-3β
Masashi Kitazawa et al.
ANNALS OF NEUROLOGY (2008)
The septic brain
Emilio L. Streck et al.
NEUROCHEMICAL RESEARCH (2008)
The GSK3 hypothesis of Alzheimer's disease
Claudie Hooper et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Unravelling the pathogenesis of inflammatory bowel disease
R. J. Xavier et al.
NATURE (2007)
Systematic discovery of in vivo phosphorylation networks
Rune Linding et al.
CELL (2007)
Role of glycogen synthase kinase-3 in insulin resistance and type 2 diabetes
Erik J. Henriksen et al.
CURRENT DRUG TARGETS (2006)
Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease
L Ho et al.
FASEB JOURNAL (2004)
1-azakenpaullone is a selective inhibitor of glycogen synthase kinase-3β
C Kunick et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
GSK3 inhibitors: Development and therapeutic potential
P Cohen et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418
R Bhat et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Structure of GSK3β reveals a primed phosphorylation mechanism
E ter Haar et al.
NATURE STRUCTURAL BIOLOGY (2001)
C-terminal fragment of amyloid precursor protein induces astrocytosis
JH Bach et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Crystal structure of glycogen synthase kinase 3β:: Structural basis for phosphate-primed substrate specificity and autoinhibition
R Dajani et al.
CELL (2001)
Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation
KP Hoeflich et al.
NATURE (2000)
Share Paper
